| Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo R Rattan, RP Graham, JL Maguire, S Giri, V Shridhar Neoplasia 13 (5), 483-IN28, 2011 | 410 | 2011 |
| Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer MJ Truty, ML Kendrick, DM Nagorney, RL Smoot, SP Cleary, RP Graham, ... Annals of surgery 273 (2), 341-349, 2021 | 395 | 2021 |
| Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma RP Graham, EGB Fritcher, E Pestova, J Schulz, LA Sitailo, G Vasmatzis, ... Human pathology 45 (8), 1630-1638, 2014 | 339 | 2014 |
| Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer S Giri, A Karakoti, RP Graham, JL Maguire, CM Reilly, S Seal, R Rattan, ... PloS one 8 (1), e54578, 2013 | 282 | 2013 |
| Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma BR Kipp, JS Voss, SE Kerr, EGB Fritcher, RP Graham, L Zhang, ... Human pathology 43 (10), 1552-1558, 2012 | 275 | 2012 |
| Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma E Loeuillard, J Yang, ELN Buckarma, J Wang, Y Liu, C Conboy, ... The Journal of clinical investigation 130 (10), 5380-5396, 2020 | 261 | 2020 |
| DNAJB1-PRKACA is specific for fibrolamellar carcinoma RP Graham, L Jin, DL Knutson, SM Kloft-Nelson, PT Greipp, ... Modern pathology 28 (6), 822-829, 2015 | 175 | 2015 |
| Worldwide Frequency of Commonly Detected EGFR Mutations RP Graham, AL Treece, NI Lindeman, P Vasalos, M Shan, LJ Jennings, ... Archives of pathology & laboratory medicine 142 (2), 163-167, 2018 | 174 | 2018 |
| SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior JL Sauter, RP Graham, BT Larsen, SM Jenkins, AC Roden, JM Boland Modern Pathology 30 (10), 1422-1432, 2017 | 165 | 2017 |
| Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma X Wang, KL Bledsoe, RP Graham, YW Asmann, DS Viswanatha, JE Lewis, ... Nature genetics 46 (7), 666-668, 2014 | 152 | 2014 |
| Tumor budding in colorectal carcinoma: confirmation of prognostic significance and histologic cutoff in a population-based cohort RP Graham, RA Vierkant, LS Tillmans, AH Wang, PW Laird, ... The American journal of surgical pathology 39 (10), 1340-1346, 2015 | 150 | 2015 |
| Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study RPD Graham, S Dry, X Li, S Binder, A Bahrami, SC Raimondi, A Dogan, ... The American journal of surgical pathology 35 (11), 1615-1625, 2011 | 131 | 2011 |
| Gastroblastoma harbors a recurrent somatic MALAT1–GLI1 fusion gene RP Graham, AA Nair, JI Davila, L Jin, J Jen, WR Sukov, TT Wu, ... Modern Pathology 30 (10), 1443-1452, 2017 | 124 | 2017 |
| Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis JA Johnson, F Cetta, RP Graham, TC Smyrk, DJ Driscoll, SD Phillips, ... The Journal of thoracic and cardiovascular surgery 146 (1), 140-145, 2013 | 109 | 2013 |
| Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for … FC Gleeson, SE Kerr, BR Kipp, JS Voss, DM Minot, ZJ Tu, MR Henry, ... Oncotarget 7 (34), 54526, 2016 | 108 | 2016 |
| Mismatch repair deficiency: The what, how and why it is important MC Olave, RP Graham Genes, Chromosomes and Cancer 61 (6), 314-321, 2022 | 100 | 2022 |
| Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS S Edogawa, AL Edwinson, SA Peters, LL Chikkamenahalli, W Sundt, ... Gut 69 (1), 62-73, 2020 | 99 | 2020 |
| Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases KJ Fritchie, L Jin, X Wang, RP Graham, MS Torbenson, JE Lewis, ... Histopathology 69 (6), 930-936, 2016 | 96 | 2016 |
| Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma TA Dinh, ECM Vitucci, E Wauthier, RP Graham, WA Pitman, T Oikawa, ... Scientific reports 7 (1), 44653, 2017 | 92 | 2017 |
| PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: a fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant RP Graham, SW Weiss, WR Sukov, JR Goldblum, SD Billings, S Dotlic, ... The American journal of surgical pathology 37 (11), 1751-1755, 2013 | 90 | 2013 |